Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ · Healthcare
Orchestra BioMed Holdings, Inc. Gross Profit 2022–2025
Orchestra BioMed Holdings, Inc. annual/quarterly gross profit history and growth rate from 2022 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Orchestra BioMed Holdings, Inc. gross profit for the quarter ending March 31, 2026 was 78000, a 90.53% decrease year-over-year.
- Orchestra BioMed Holdings, Inc. gross profit for the twelve months ending March 31, 2026 was 2.5 M, a 4.32% decrease year-over-year.
- Orchestra BioMed Holdings, Inc. annual gross profit for 2025 was 33.3 M, a 1267.79% increase from 2024.
- Orchestra BioMed Holdings, Inc. annual gross profit for 2024 was 2.4 M, a 5.44% decrease from 2023.
- Orchestra BioMed Holdings, Inc. annual gross profit for 2023 was 2.6 M, a 22.52% decrease from 2022.
- Orchestra BioMed Holdings, Inc. annual gross profit for 2022 was 3.3 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Orchestra BioMed Holdings, Inc. Gross Profit — FAQ
Orchestra BioMed Holdings, Inc. (OBIO) gross profit over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Orchestra BioMed Holdings, Inc.'s gross profit?
Orchestra BioMed Holdings, Inc. (OBIO) reported gross profit of $33M for fiscal 2025.
Where can I see OBIO's gross profit history?
The chart and table above show Orchestra BioMed Holdings, Inc.'s gross profit by year and by quarter, including the growth rate.